1. Department of Pathology, Brigham and Women’s Hospital, Boston, MA;
2. Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom;
3. Center for Immuno-Oncology and
4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
5. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands;
6. PerkinElmer, Inc., Hopkinton, MA; and
7. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA